JERSEY CITY, N.J.–(BUSINESS WIRE)– #AMD–Character Bio, a clinical-stage biotechnology company developing new medicines for vision-threatening diseases, will present at investor conferences.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.